Congress Chair

Dr. Raanan Berger

 Dr. Raanan Berger is director of the Institute of Oncology at the Sheba Medical Center, which is Israel’s national hospital and the largest medical center in the Middle East. He is also secretary of the Israeli Society of Clinical Oncology and Radiotherapy. His MD and PhD degrees are from Tel Aviv University and he was a postdoctoral fellow at the Dana Farber Cancer Institute at Harvard Medical School. Nine years ago, he established the Riva Koschitzky Oncology Clinical Research Center, at Sheba, which is the largest center for all-phase oncology clinical trials in Israel, currently conducting over 200 advanced clinical trials backed by the biggest pharmaceutical conglomerates and top scientists in the world.

Dr Berger led his institute to become one of the most active partners in the world wide initiative networking (WIN) Consortium and he is the PI of the WINTHER-1 trial for personalized cancer medicine.  

Organizing Committee

  • Raanan Berger (Congress Chairperson) -  M.D./Ph.D; Director, Division of Medical Oncology, Sheba Medical Center, Tel Hashomer, Israel
  • Aliza Ackerstein - Early Phase Clinical Trials Program Director; Division of Medical Oncology, Sheba Medical Center, Tel Hashomer, Israel
  • Talia Golan  - Phase I Medical Director, Division of Medical Oncology, Sheba Medical Center, Tel Hashomer, Israel
  • Michele Milella - MD.; Division of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy
  • Jens Siveke - Director, Division of Solid Tumor Translational Oncology at the partner site Essen of the German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) and Head of the Clinical Pancreatic Cancer Program at the West German Cancer Center, University Hospital Essen, Germany
  • Robin Foà - Professor of Hematology and Head of Hematology at the “Sapienza” University of Rome, Italy